Board of Scientific Counselors, National Institute for Occupational Safety and Health (BSC, NIOSH), 51113-51114 [2022-17841]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 160 / Friday, August 19, 2022 / Notices
Request for Comments
In accordance with the Paperwork
Reduction Act, 44 U.S.C. 3501–3520,
comments on AHRQ’s information
collection are requested with regard to
any of the following: (a) whether the
proposed collection of information is
necessary for the proper performance of
AHRQ’s health care research and health
care information dissemination
functions, including whether the
information will have practical utility;
(b) the accuracy of AHRQ’s estimate of
burden (including hours and costs) of
the proposed collection(s) of
information; (c) ways to enhance the
quality, utility and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: August 15, 2022.
Marquita Cullom,
Associate Director.
[FR Doc. 2022–17848 Filed 8–18–22; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2022–0098; NIOSH 278]
Board of Scientific Counselors,
National Institute for Occupational
Safety and Health (BSC, NIOSH)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting and request
for comment.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
of the Board of Scientific Counselors,
National Institute for Occupational
Safety and Health (BSC, NIOSH). This
meeting is open to the public via virtual
meeting, limited only by the number of
web conference lines (500 web
conference lines are available). Time
will be available for public comment.
DATES: The meeting will be held on
October 4, 2022, from 10:00 a.m. to 3:00
p.m., EDT.
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:26 Aug 18, 2022
Jkt 256001
Written comments must be received
on or before September 27, 2022.
ADDRESSES: If you wish to attend the
meeting, please register at the NIOSH
website at https://www.cdc.gov/niosh/
bsc/ or by telephone at (202) 245–0649
no later than September 27, 2022.
You may submit comments, identified
by Docket No. CDC–2022–0098;
NIOSH–278, by either of the methods
listed below. Do not submit comments
for the docket by email. CDC does not
accept comments for the docket by
email.
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Sherri Diana, NIOSH Docket
Office, National Institute for
Occupational Safety and Health, 1090
Tusculum Avenue, Mailstop C–34,
Cincinnati, Ohio 45226. Attn: Docket
No. CDC–2022–0098; NIOSH–278.
Instructions: All submissions received
must include the Agency name and
Docket Number. Docket number CDC–
2022–0098; NIOSH–278 will close
September 27, 2022.
FOR FURTHER INFORMATION CONTACT:
Maria Strickland, M.P.H., Designated
Federal Officer, BSC, NIOSH, CDC,
Patriots Plaza 1, 395 E Street SW, Suite
9200, Washington, DC 20201;
Telephone: (202) 245–0649; Email:
MStrickland2@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Secretary of Health and
Human Services, the Assistant Secretary
for Health, and by delegation the
Director, Centers for Disease Control
and Prevention, are authorized under
Sections 301 and 308 of the Public
Health Service Act to conduct directly,
or by grants or contracts, research,
experiments, and demonstrations
relating to occupational safety and
health and to mine health.
The Board of Scientific Counselors,
National Institute for Occupational
Safety and Health provides advice to the
Director, National Institute for
Occupational Safety and Health, on
NIOSH research and prevention
programs. The Board also provides
guidance on the Institute’s research
activities related to developing and
evaluating hypotheses, systematically
documenting findings, and
disseminating results. In addition, the
Board evaluates the degree to which the
activities of NIOSH: (1) conform to those
standards of scientific excellence
appropriate for federal scientific
institutions in accomplishing objectives
in occupational safety and health; (2)
address currently relevant needs in the
fields of occupational safety and health
either alone or in conjunction with
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
51113
other known activities inside and
outside of NIOSH; and (3) produce their
intended results in addressing
important research questions in
occupational safety and health, both in
terms of applicability of the research
findings and dissemination of the
findings.
Matters To Be Considered: The agenda
for the meeting addresses health
communications, updates from the
National Firefighter Registry
Subcommittee, progress on the NIOSH
Evaluation Capacity Building Plan, and
implementation science. Agenda items
are subject to change as priorities
dictate.
The agenda is posted on the NIOSH
website at https://www.cdc.gov/niosh/
bsc/.
Public Participation
Written Public Comment: Written
comments will be accepted per the
instructions provided in the addresses
section above. Comments received in
advance of the meeting are part of the
public record and are subject to public
disclosure. They will be included in the
official record of the meeting. Do not
include any information in your
comment or supporting materials that
you consider confidential or
inappropriate for public disclosure. If
you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be on
public display. CDC will review all
submissions and may choose to redact,
or withhold, submissions containing
private or proprietary information such
as Social Security numbers, medical
information, inappropriate language, or
duplicate/near duplicate examples of a
mass-mail campaign. CDC will carefully
consider all comments submitted into
the docket.
Written comments received by
September 27, 2022, will be provided to
the Board prior to the meeting.
Oral Public Comment: The public is
welcome to participate during the
public comment period, from 1:00 p.m.
to 1:15 p.m., EDT, October 4, 2022. Each
commenter will be provided up to 5
minutes for comment. A limited number
of time slots are available and will be
assigned on a first-come, first-served
basis. Members of the public who wish
to address the BSC, NIOSH are
requested to contact the Designated
Federal Officer for scheduling purposes
(see FOR FURTHER INFORMATION CONTACT
above).
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
E:\FR\FM\19AUN1.SGM
19AUN1
51114
Federal Register / Vol. 87, No. 160 / Friday, August 19, 2022 / Notices
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–17841 Filed 8–18–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Presidential Advisory
Council on HIV/AIDS
Department of Health and
Human Services, Office of the Secretary,
Office of the Assistant Secretary for
Health.
ACTION: Notice of a hybrid meeting.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Service is hereby giving notice that the
Presidential Advisory Council on HIV/
AIDS (PACHA or the Council) will
convene the 74th full council meeting
on Monday, September 19, 2022 and
September 20, 2022. The meeting will
convene in Los Angeles, California and
it will also utilize virtual technologies.
The meeting will be open to the public.
Due to limited space, pre-registration is
encouraged for members of the public
who wish to attend the meeting inperson. Please email your name to
PACHA@hhs.gov by close of business
Friday, September 9, 2022 to prereigster. There will be a public comment
session during the meeting; preregistration is required to provide public
comment. To pre-register to provide
public comment, please send an email
to PACHA@hhs.gov and include your
name, organization, and title by close of
business Friday, September 9, 2022. If
you decide you would like to provide
public comment but do not pre-register,
you may submit your written statement
by emailing PACHA@hhs.gov by close of
business Tuesday, September 27, 2022.
The meeting agenda will be posted on
the PACHA page on HIV.gov at https://
www.hiv.gov/federal-response/pacha/
about-pacha prior to the meeting.
DATES: The meeting will be held on
Monday, September 19, 2022 from
approximately 4:00–10:00 p.m. (ET) and
September 20, 2022 from approximately
3:30–8:00 p.m. (ET).
ADDRESSES: The meeting will be located
at the Martin Luther King Jr. Outpatient
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:26 Aug 18, 2022
Jkt 256001
Building, 1670 E 120th Street, Los
Angeles, CA 90059. (The closest metro
stop the Willowbrook/Rosa Parks
station.) To attend the meeting virtually,
please visit www.hhs.gov/live.
FOR FURTHER INFORMATION CONTACT: Ms.
Caroline Talev, MPA, Senior
Management Analyst, at PACHA@
hhs.gov or Caroline.Talev@hhs.gov.
Additional information can be obtained
by accessing the Council’s page on the
HIV.gov site at www.hiv.gov/pacha.
SUPPLEMENTARY INFORMATION: PACHA
was established by Executive Order
12963, dated June 14, 1995, as amended
by Executive Order 13009, dated June
14, 1996 and is currently operating
under the authority given in Executive
Order 14048, dated September 30, 2021.
The Council was established to provide
advice, information, and
recommendations to the Secretary
regarding programs and policies
intended to promote effective HIV
diagnosis, treatment, prevention, and
quality care services. The functions of
the Council are solely advisory in
nature.
The Council consists of not more than
35 members. Council members are
selected from prominent community
leaders with particular expertise in, or
knowledge of, matters concerning HIV
and AIDS, public health, global health,
population health, philanthropy,
marketing or business, as well as other
national leaders held in high esteem
from other sectors of society. PACHA
selections also include persons with
lived HIV experience and racial/ethnic
and sexual and gender minority persons
disproportionately affected by HIV.
Council members are appointed by the
Secretary.
Dated: August 9, 2022.
B. Kaye Hayes,
Deputy Assistant Secretary for Infectious
Disease, Director, Office of Infectious Disease
and HIV/AIDS Policy, Executive Director,
Presidential Advisory Council on HIV/AIDS,
Office of the Assistant Secretary for Health,
Department of Health and Human Services.
[FR Doc. 2022–17812 Filed 8–18–22; 8:45 am]
BILLING CODE 4150–43–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Announcement of the President’s
Advisory Commission on Asian
Americans, Native Hawaiians, and
Pacific Islanders Meeting
White House Initiative on
Asian Americans, Native Hawaiians,
and Pacific Islanders, Office for Civil
Rights, Office of the Secretary,
AGENCY:
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
Department of Health and Human
Services.
ACTION: Notice of meeting.
As required by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Services (HHS) is hereby giving notice
that the President’s Advisory
Commission on Asian Americans,
Native Hawaiians, and Pacific Islanders
will hold a meeting on September 28,
2022. The meeting is the third in a
series of federal advisory committee
meetings regarding the development of
recommendations to promote equity,
justice, and opportunity for Asian
American, Native Hawaiian, and Pacific
Islander (AA and NHPI) communities.
The meeting is open to the public and
will be live streamed. The Commission,
co-chaired by HHS Secretary Xavier
Becerra and the U.S. Trade
Representative Ambassador Katherine
Tai, will advise the President on: the
development, monitoring, and
coordination of executive branch efforts
to advance equity, justice, and
opportunity for AA and NHPI
communities in the United States,
including efforts to close gaps in health,
socioeconomic, employment, and
educational outcomes; policies to
address and end anti-Asian bias,
xenophobia, racism, and nativism, and
opportunities for the executive branch
to advance inclusion, belonging, and
public awareness of the diversity and
accomplishments of AA and NHPI
people, cultures, and histories; policies,
programs, and initiatives to prevent,
report, respond to, and track anti-Asian
hate crimes and hate incidents; ways in
which the Federal Government can
build on the capacity and contributions
of AA and NHPI communities through
equitable Federal funding, grantmaking,
and employment opportunities; policies
and practices to improve research and
equitable data disaggregation regarding
AA and NHPI communities; policies
and practices to improve language
access services to ensure AA and NHPI
communities can access Federal
programs and services; and strategies to
increase public-and private-sector
collaboration, and community
involvement in improving the safety
and socioeconomic, health, educational,
occupational, and environmental wellbeing of AA and NHPI communities.
DATES: The Commission will meet on
September 28, 2022 from 9:30 a.m. to
approximately 5:30 p.m. Eastern Time
(ET). The confirmed time and agenda
will be posted on the website for the
President’s Advisory Commission on
Asian Americans, Native Hawaiians,
SUMMARY:
E:\FR\FM\19AUN1.SGM
19AUN1
]]>Agencies
[Federal Register Volume 87, Number 160 (Friday, August 19, 2022)]
[Notices]
[Pages 51113-51114]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-17841]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2022-0098; NIOSH 278]
Board of Scientific Counselors, National Institute for
Occupational Safety and Health (BSC, NIOSH)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting of the Board of Scientific Counselors,
National Institute for Occupational Safety and Health (BSC, NIOSH).
This meeting is open to the public via virtual meeting, limited only by
the number of web conference lines (500 web conference lines are
available). Time will be available for public comment.
DATES: The meeting will be held on October 4, 2022, from 10:00 a.m. to
3:00 p.m., EDT.
Written comments must be received on or before September 27, 2022.
ADDRESSES: If you wish to attend the meeting, please register at the
NIOSH website at https://www.cdc.gov/niosh/bsc/ or by telephone at
(202) 245-0649 no later than September 27, 2022.
You may submit comments, identified by Docket No. CDC-2022-0098;
NIOSH-278, by either of the methods listed below. Do not submit
comments for the docket by email. CDC does not accept comments for the
docket by email.
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: Sherri Diana, NIOSH Docket Office, National
Institute for Occupational Safety and Health, 1090 Tusculum Avenue,
Mailstop C-34, Cincinnati, Ohio 45226. Attn: Docket No. CDC-2022-0098;
NIOSH-278.
Instructions: All submissions received must include the Agency name
and Docket Number. Docket number CDC-2022-0098; NIOSH-278 will close
September 27, 2022.
FOR FURTHER INFORMATION CONTACT: Maria Strickland, M.P.H., Designated
Federal Officer, BSC, NIOSH, CDC, Patriots Plaza 1, 395 E Street SW,
Suite 9200, Washington, DC 20201; Telephone: (202) 245-0649; Email:
[email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Secretary of Health and Human Services, the Assistant
Secretary for Health, and by delegation the Director, Centers for
Disease Control and Prevention, are authorized under Sections 301 and
308 of the Public Health Service Act to conduct directly, or by grants
or contracts, research, experiments, and demonstrations relating to
occupational safety and health and to mine health.
The Board of Scientific Counselors, National Institute for
Occupational Safety and Health provides advice to the Director,
National Institute for Occupational Safety and Health, on NIOSH
research and prevention programs. The Board also provides guidance on
the Institute's research activities related to developing and
evaluating hypotheses, systematically documenting findings, and
disseminating results. In addition, the Board evaluates the degree to
which the activities of NIOSH: (1) conform to those standards of
scientific excellence appropriate for federal scientific institutions
in accomplishing objectives in occupational safety and health; (2)
address currently relevant needs in the fields of occupational safety
and health either alone or in conjunction with other known activities
inside and outside of NIOSH; and (3) produce their intended results in
addressing important research questions in occupational safety and
health, both in terms of applicability of the research findings and
dissemination of the findings.
Matters To Be Considered: The agenda for the meeting addresses
health communications, updates from the National Firefighter Registry
Subcommittee, progress on the NIOSH Evaluation Capacity Building Plan,
and implementation science. Agenda items are subject to change as
priorities dictate.
The agenda is posted on the NIOSH website at https://www.cdc.gov/niosh/bsc/.
Public Participation
Written Public Comment: Written comments will be accepted per the
instructions provided in the addresses section above. Comments received
in advance of the meeting are part of the public record and are subject
to public disclosure. They will be included in the official record of
the meeting. Do not include any information in your comment or
supporting materials that you consider confidential or inappropriate
for public disclosure. If you include your name, contact information,
or other information that identifies you in the body of your comments,
that information will be on public display. CDC will review all
submissions and may choose to redact, or withhold, submissions
containing private or proprietary information such as Social Security
numbers, medical information, inappropriate language, or duplicate/near
duplicate examples of a mass-mail campaign. CDC will carefully consider
all comments submitted into the docket.
Written comments received by September 27, 2022, will be provided
to the Board prior to the meeting.
Oral Public Comment: The public is welcome to participate during
the public comment period, from 1:00 p.m. to 1:15 p.m., EDT, October 4,
2022. Each commenter will be provided up to 5 minutes for comment. A
limited number of time slots are available and will be assigned on a
first-come, first-served basis. Members of the public who wish to
address the BSC, NIOSH are requested to contact the Designated Federal
Officer for scheduling purposes (see FOR FURTHER INFORMATION CONTACT
above).
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been
[[Page 51114]]
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-17841 Filed 8-18-22; 8:45 am]
BILLING CODE 4163-18-P
